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ABSTRACT The Scientific Method is the series of processes by which hypotheses, ideas and theories 
are shown to be true beyond a reasonable scientific doubt. Most science ‘fact’ is expressed in terms 
of probabilities rather than certainties. Thus, by means of statistical calculations, researchers aim 
to determine whether an observed association between two events or characteristics may have 
occurred by chance (coincidence), whether they frequently occur together (correlation) or whether 
they occur together because one causes the other (causative relationship). In this article we review 
the Scientific Method and consider the statistical tests that are applied. We then focus on the 
occasions when science changes its mind and review eight such occurrences.
The role of science can be argued as providing 
new knowledge that consists of facts, which 
in turn come from evidence generated when 
testing hypotheses. But during the quest for new 
knowledge it sometimes happens that existing 
knowledge, or well-founded theories that fall short 
of being absolute fact but nevertheless have much 
evidence to bear them out, needs correcting. This 
is when science does a U-turn. This is one of the 
defined rules that any competent scientist will hold 
dear, and yet it goes against human nature. This is 
because of the normal need to fulfil one’s ingrained 
self-serving confirmation bias – the tendency to 
search for evidence to confirm pre-existing beliefs, 
especially those in which the individual has an 
investment, emotional or otherwise:
Faced with the choice between changing one’s 
mind and proving that there is no need to do so, 
almost everyone gets busy on the proof. (John 
Kenneth Galbraith; https://en.wikiquote.org/wiki/
John_Kenneth_Galbraith)
And so the ability to change one’s mind in the 
light of new evidence is one that develops during 
the career of the aspiring scientist, and those that 
have reached the dizziest heights of our trade are 
often the most disarmingly honest:
In science it often happens that scientists say, 
‘You know that’s a really good argument; my 
position is mistaken,’ and then they actually 
change their minds and you never hear that old 
view from them again. . . . I cannot recall the last 
time something like that has happened in politics 
or religion. (Carl Sagan, 1987 CSICOP address; 
https://en.wikiquote.org/wiki/Carl_Sagan)
When my information changes, I alter my 
conclusions. What do you do, sir? (John 
Maynard Keynes; https://en.wikiquote.org/wiki/
John_Maynard_Keynes)
This skill attribute is probably more finely 
developed in those who have it woven into their 
professional ethical personae and it may be less 
well understood by the layperson. Society often 
cannot understand it when science changes its 
mind, and that which hitherto was stated as fact 
becomes fiction and vice versa.
During the 2016 discussion concerning 
childhood obesity, Public Health England had 
to step in and describe as ‘irresponsible’ the 
advice given by the National Obesity Forum that 
eating fat could help combat obesity and type 2 
diabetes (BBC News, 2016). The sight of a public 
body and a charity engaged in two diametrically 
opposed scientific views, each apparently having 
evidence to support their case, appeared to add 
to the pre-existing confusion and wavering 
confidence in science, causing the then-MP for 
Leicester East and Chair of the Home Affairs 
Select Committee, Keith Vaz, to opine:
Ordinary people are now caught in a whirlwind 
of conflicting advice at a time when they 
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desperately need clarity, consistency and straight 
talk. Quite simply they don’t know where to 
turn. (Keith Vaz; https://hansard.parliament.uk/
Commons/2016-05-23/debates/1605231000001/
DietaryAdviceAndChildhoodObesityStrategy)
To some degree, Mr Vaz had a point: to 
anyone unfamiliar with the Scientific Method 
(Figure 1), the periodic occasions when science 
changes its stance appear to be confidence-
sapping and serve to undermine the public’s trust 
in science. Once, science claimed, it was healthy 
to drink a glass of red wine a day; then science 
later recanted and said that it wasn’t after all. 
Understanding of the Scientific Method as well 
as the knowledge it produces may be a key to 
offering the public the reassurance it seeks, that 
science really does know what it’s talking about.
The Scientific Method, certainty and 
probability
Scientific research is not presented in terms of 
certainties but in terms of probability. Thus, by 
means of mathematical calculations, researchers 
aim to determine whether an observed association 
between two events or characteristics may have 
occurred by chance (coincidence), whether they 
frequently occur together (correlation) or whether 
they occur together because one causes the other 
(causative relationship).
Let us consider two human conditions. 
The first condition is  schizophrenia, a severe 
psychiatric condition in which people affected 
frequently report delusions (for example that their 
neighbours are spying on them) and hallucinations 
(for example hearing a voice or voices). It affects 
up to about 13 per 1000 individuals during 
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their lifetime (Perälä et al., 2007). The second 
condition is tonic–clonic (or grand mal) epilepsy, 
in which people affected experience seizures 
during which, in the tonic phase, the body 
becomes entirely rigid and, in the clonic phase, 
there is uncontrolled jerking. These may last a 
few seconds or several minutes. Approximately 
5 per 1000 of the population experience tonic–
clonic seizures (Joint Epilepsy Council, 2011). 
Mathematically, the chance of a single individual 
being affected by both schizophrenia and tonic–
clonic seizures is 6.5 per 100 000 individuals (or 
0.065 per 1000; 0.5% × 1.3%). Early in the last 
century, this statistic led doctors to believe that 
patients with tonic–clonic epilepsy were protected 
against schizophrenia because they had never seen 
a patient with both. This belief was implemented 
by attempting to treat schizophrenia by inducing 
epilepsy, initially by injections of chemicals 
such as camphor and later by passing an electric 
current across the head (electroconvulsive therapy, 
ECT). Today, ECT is still used, but usually for the 
treatment of depression-like illnesses that are quite 
different from schizophrenia; rarely is ECT used 
for the treatment of schizophrenia. The observed 
relationship between epilepsy and schizophrenia 
was not preventive but purely ‘coincidental’. 
If the probability of ever seeing a patient with 
both epilepsy and schizophrenia is 0.0065%, the 
probability of never seeing a patient with both is 
99.9935%. This is an example of an observation 
and speculated relationship that turned out to be 
wrong. Today, this fact would be revealed quickly 
by considering the relative prevalences of the two 
conditions. The doctors’ belief, however, was not 
without value as it did lead to the development of 
a treatment for another illness.
Let us consider another, non-medical, 
example. If you were to take a shuffled deck of 
52 playing cards and deal four cards off the top 
of the deck, you would probably suspect that the 
deck was ‘rigged’ if the first four cards were all 
aces. You would know that, mathematically, such 
an event is possible, but in reality it is highly 
unlikely. The chance of the first four cards dealt 
from a shuffled deck being the four aces is 1 in 
270 725 ( 34 2 152 51 50 49´ ´ ´ ) or 0.00037%. It could 
happen by chance, but it is highly unlikely. You 
would conclude that the deck of cards was fixed. 
In the case of the schizophrenia and epilepsy 
belief, the probability of the lack of association 
of the two conditions occurring by chance was 
99.99% – it should never have been questioned. 
In most scientific research, if the probability of 
an observed event occurring by chance is less 
than 5%, it is concluded that the event has not 
occurred randomly but that something has been 
done to make it happen. In scientific terminology, 
a results is termed ‘significant’ if the probability 
of the observation occurring by chance is less 
than 5%.
To put this into context, when dealing from 
a shuffled deck of cards, the probability that 
the first card will be red (diamond or heart 
suit) is 26/52 (50%); the probability that the 
second card is also red is 25/51 (49%) and that 
the third card is also red is 24/50 (48%). Thus, 
dealing three cards of the same colour ‘off the 
top’ could occur on 11.8% (0.5 × 0.49 × 0.48) of 
occasions. The probability of dealing four cards 
of the same colour off the top would be 5.5%. 
By scientific convention, if someone deals four 
cards of the same colour off the top of a shuffled 
deck of cards, you must accept that this is a 
statistical possibility and therefore not question 
the honesty nor integrity of the dealer. But if they 
deal five cards of the same colour off the top 
(the probability is 2.53%), you might choose to 
challenge them; in scientific terms, you would 
state that the observed pattern of dealt cards is 
unlikely to have occurred by chance, and therefore 
the deal has been influenced by the dealer. When 
making your challenge, you would have to accept 
that the sequence of cards could have been dealt, 
randomly, by an honest dealer, on 2.53% of deals, 
i.e. about 1 in 40 deals. There is a 1 in 40 chance 
that your challenge is incorrect and that, rather 
than receiving compensation from a crooked 
dealer, you lose the case and have to pay them 
compensation for defamation of character.
In scientific research, the 5% probability 
hurdle is used because it raises suspicions 
that the observed results have not occurred by 
chance at a relatively low threshold (1 in 20); 
it encourages further research. If the observed 
results have actually occurred by chance, the 
probability of a second experiment producing 
the same significant results, again by chance, 
is 5% times 5%, i.e. 0.25%. This highlights the 
importance of repeating research in an attempt to 
replicate results. Typically, researchers present 
their findings in terms of probability, not certainty. 
They would not claim that a card dealer was 
crooked; they would claim that the probability 
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(p) of the card dealer being honest is 0.0253 
(or 2.53%), and therefore the findings suggest 
crookedness. The smaller the p value, the greater 
the likelihood that the observations are real, true 
or significant.
The concept of probability versus certainty 
has led to several incorrect scientific conclusions 
throughout history and, importantly, the popular 
press have frequently promulgated incorrect 
theories without appreciating the statistical 
assumptions underlying those theories.
Cases
1. The cause of cholera
Cholera was at one time the cause of death of 
millions of people, with pandemics routinely 
sweeping continents. Before 1854, it was believed 
to be spread via ‘malodorous airs’ (https://
en.wikipedia.org/wiki/John_Snow). By charting 
specific cases within a narrowly defined area of 
London, John Snow developed a theory that it 
was transmitted by infected water. He removed 
the handle from a water pump in Broad Street, an 
action that is generally accepted to have halted the 
outbreak and at the same time to have proven how 
the disease is transmitted. It transpired that the pump 
had been situated too close to a disused cesspit into 
which a nappy from a cholera-infected baby had 
been thrown. Interestingly, the scientific community 
later rejected Snow’s assertions, partly because 
society wasn’t prepared to accept the distasteful 
faecal–oral route proposed. Only when William 
Farr, hitherto one of Snow’s antagonists, scrutinised 
Snow’s dot maps and other data, and his own 
gathered data, was Snow’s hypothesis vindicated.
2. Vitamin C and the common cold
The apocryphal link between vitamin C and 
resistance to the common cold is one of the 
science folklores that seems still to be propagated 
within society in spite of science’s best efforts. 
Somewhat surprisingly, it was originally proposed 
by Linus Pauling (1976), the only scientist to win 
two unshared Nobel prizes. He is largely the cause 
of the mistaken belief that vitamin C affects one’s 
propensity to catch the common cold. He also 
suggested that large doses of vitamin C caused 
the majority of 100 terminal cancer patients to 
survive 3–4 times as long as would otherwise 
have done. Subsequent double-blind studies of 
both of these claims showed them to be false 
and yet the myth that vitamin C is a cure for 
the cold is still pervasive (www.quackwatch.
com/01QuackeryRelatedTopics/pauling.html). It 
has been shown that Pauling cherry-picked from 
the literature, citing the articles that supported his 
assertion and ignoring those that did not.
3. Red wine, antioxidants and longevity
For some years, society was given the definite 
impression that drinking a glass of red wine 
a day afforded verifiable health benefits. This 
so-called ‘French Paradox’ considered the low 
incidence of coronary heart disease in France and 
attributed it to red wine in general and one of its 
contents, resveratrol, which is an antioxidant, in 
particular. The underlying theory about resveratrol, 
polyphenols and antioxidants in general is that they 
mop up free radicals. Free radicals are atoms or 
molecules with an unpaired electron which are very 
reactive and so will bind to almost any molecule 
(including DNA). This will lead to cell death and, 
over time, to premature signs of ageing. It might 
be logical to draw the conclusion that a molecule 
that sweeps up free radicals might reduce ageing, 
or its appearance at least. This belies the fact that 
sometimes the body produces its own free radicals: 
leucocytes (white blood cells) produce them to 
kill off pathogens. Ipso facto, sometimes free 
radicals help rather than hinder. In the 1980s, there 
appeared to be a rush of research suggesting the 
positive health effects of antioxidants, both in terms 
of longevity and in reducing ageing (or at least the 
appearance of it). For example, it was proposed that 
there is a positive relationship between high uptake 
of β-carotene (an antioxidant) and reduced risk of 
cancer. While on the subject of carotenes, we can 
put the other carotene myth to bed: eating carrots 
does not do anything for your eyesight (although 
carotenoids are involved in the pathway for sight 
perception) – this was a deliberate myth promoted 
by the War Office during the Second World War to 
explain the increased success rate of Allied fighters, 
who always appeared to know where the Luftwaffe 
were. It was said that the pilots had sharp eyesight 
because they ate many carrots. It was nothing to 
do with carrots and everything to do with newly 
discovered radar, a secret of which it was critical to 
keep from the Axis powers.
The French Paradox appears to be another 
case where correlation does not necessarily mean 
causation (NHS Choices, 2014):
this prospective study of nearly 800 older 
community-dwelling adults shows no association 
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between urinary resveratrol metabolites and 
longevity. This study suggests that dietary 
resveratrol from Western diets in community-
dwelling older adults does not have a substantial 
influence on inflammation, cardiovascular 
disease, cancer or longevity.
4. MMR and autism
The MMR and autism controversy has been 
described as ‘perhaps, the most damaging 
medical hoax of the last 100 years’ (Flaherty, 
2011). The root cause was a single individual 
researcher with his own agenda, which, when 
added to the shrill support of the tabloids, created 
fear and uncertainty among parents. In 1998, a 
now-retracted article (Wakefield et al., 1998) 
was published in The Lancet which claimed 
that colitis and autism spectrum disorders are 
linked to the combined measles, mumps and 
rubella (MMR) vaccine. The media pounced 
on this proclamation and, as a result, thousands 
of children either underwent three separate 
vaccinations or no vaccinations at all. Only as 
a result of an investigation by a Sunday Times 
journalist, Brian Deer (http://briandeer.com/mmr/
lancet-paper.htm), was the research debunked 
(although one might argue that it was never 
‘bunked’ in the first place). In hindsight, the 
flaws in the article appear glaringly obvious: the 
‘sample’ size was 12 children and the reported 
correlation between the vaccination and bowel 
or behavioural problems in eight of the 12 was 
anecdotal. The study did not constitute a case 
series, cohort study or case–control study, as 
would normally be required (Goldacre, 2009). 
Moreover, the fact that all 12 gathered in the same 
place (the Paediatric Gastroenterology Clinic at 
the Royal Free Hospital in London) meant that 
they were effectively a self-selecting, non-random 
sample, each with bowel disorders. It later 
transpired that Andrew Wakefield, the principal 
investigator, had failed to disclose a conflict of 
interest inasmuch as he had an interest in a patent 
relating to a new single measles vaccine. The 
12 children were preselected by the researchers 
and not sequential referrals as suggested in the 
article. A curious facet of this case is that the 
media stood behind the researcher, holding him 
up as the courageous lone voice fighting the 
system. Predictably, vaccination rates dropped, 
with commensurate results in terms of preventable 
deaths, and any number of parents whose children 
developed autism that they would have developed 
with or without the vaccinations went through the 
needless guilt of believing they were responsible 
for their child’s affliction.
5. The prosecutor’s fallacy
This example is not so much about how science 
changed its mind as about how statistics did 
(albeit statistics presented as science and by a 
scientist). The phrase and concept were first 
coined in 1987 by William Thompson and Edward 
Schumann (Thompson and Schumann, 1987) 
and yet the fallacy caused mother-of-two Sally 
Clark to be found guilty in 1999 of murdering 
her two babies in succession, primarily because 
of the flawed interpretation of statistics by the 
now-discredited Professor Sir Roy Meadow, who 
was considered an expert in children who came to 
harm by their parent’s hand.
The basic fallacy results from misunderstanding 
conditional probability and neglecting the prior 
odds of a defendant being guilty before that 
evidence was introduced. When a prosecutor has 
collected some evidence (for instance a DNA 
match) and has an expert testify that the probability 
of finding this evidence if the accused were 
innocent is tiny, the fallacy occurs if it is concluded 
that the probability of the accused being innocent 
must be comparably tiny. (https://en.wikipedia.org/
wiki/Prosecutor’s_fallacy)
Professor Meadow famously quoted the 
chance of two babies in the same household dying 
of SIDS (sudden infant death syndrome) as being 
1 in 73 000 000 and cited Meadow’s Law:
One sudden infant death in a family is a tragedy, 
two is suspicious and three is murder unless 
proven otherwise. (https://en.wikipedia.org/wiki/
Meadow%27s_law)
He arrived at this figure by simply multiplying 
the chance of one baby dying of SIDS by itself 
(i.e. by squaring 1 in 8543); in other words, he 
assumed that both events were totally independent 
of each other and the chance of having a second 
death by SIDS was vanishingly small if a first 
death by SIDS had occurred. He was effectively 
stating that a second SIDS death is less likely than 
the first when in fact it is more likely since there 
is likely to be some underlying cause (e.g. genetic 
predisposition or some environmental factor). This 
needs to be considered in the light of knowledge 
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existing at the time, that the probability of a 
woman developing schizophrenia immediately 
after the birth of her baby is approximately 1 per 
1000, but that the risk of developing it after the 
birth of a subsequent child is 50% if a previous 
birth has been affected (Jones, Chandra, Dazzan 
and Howard, 2014). This contrasts with the 1 per 
million that might have been calculated using the 
logic presented above.
The press at the time made much of Professor 
Meadow’s number, effectively stating that 1 in 
73 000 000 was the chance of the death of the two 
babies being accidental and therefore, crucially, 
the chance of Sally Clark being innocent. The 
jury appeared to share that view and she was 
found guilty, because they too, as well as the 
defence team, and the judge of the original trial 
and the judge of the first appeal (Goldacre, 2009) 
fell victim to the prosecutor’s fallacy. In this 
context, the fallacy can be explained as follows. 
Two babies have died, either by double SIDS 
or by double murder, both of which have a low 
probability of having taken place. But, having 
taken place, both are now far more likely because 
it has to be one or the other (or, one supposes, 
one of each). The jury should therefore have 
been directed to consider the relative likelihood 
of double murder and double SIDS and not just 
the probability of double SIDS (even if the 1 in 
73 000 000 figure was accepted, which it shouldn’t 
have been).
Although double SIDS is very rare, double infant 
murder is likely to be rarer still, so the probability 
of Clark’s innocence was quite high. Hill calculated 
the odds ratio for double SIDS to double homicide 
at between 4.5:1 and 9:1. (Hill, 2004)
Furthermore, Professor Meadow’s original 
figure for a single SIDS death of 1 in 8543 was 
also flawed, and should have been closer to 1 in 
1300. He had arrived at the figures by cherry-
picking characteristics of the Clark family that 
seemed to bolster the prosecution case by making 
SIDS seem less likely. Such factors included the 
fact that the babies came from a non-smoking 
household, the parents were affluent, middle class 
and in a stable relationship. He also ignored those 
characteristics that made SIDS more likely (the 
two babies were boys, and boys have a higher 
predisposition to SIDS).
When considering the fact that the number of 
1 in 73 000 000 would have been uppermost on 
the jury’s mind, the judges at Sally Clark’s second 
appeal said:
We rather suspect that with the graphic reference 
by Professor Meadow to the chances of backing 
long odds winners of the Grand National year 
after year it may have had a major effect on [the 
jury’s] thinking notwithstanding the efforts of the 
trial judge to down play it. (R. v. Clark, [2003] 
EWCA Crim 1020, 11 April 2003)
6. MRSA superbugs in hospitals
The MRSA scare of 2005 arose when newspapers 
in general and tabloids in particular reported a 
sharp and chilling increase in MRSA (methicillin-
resistant Staphylococcus aureus) in UK hospitals. 
MRSA is a bacterial infection that just doesn’t 
respond to normal antibiotics, and understandably 
these reports generated public disquiet. The 
manner in which the reports were covered didn’t 
help, with the Sunday Mirror famously describing 
‘the mop of death’ on one front page splash. 
The unusual aspect to this episode is that the 
reportage seemed to come before the research; 
and when hospital microbiologists attempted 
to replicate the results being screamed by the 
red tops (www.mirror.co.uk/news/world-news/
killer-bug-trains-buses-1599712) they came back 
negative. Ben Goldacre, probably the UK’s best-
known debunker of faked or flawed science, was 
instrumental in uncovering the reality (Goldacre, 
2009). It transpired that all the positive MRSA 
results emanated from one testing laboratory, 
Chemsol Ltd, run by a commercial company 
consisting of one employee, a ‘Dr’ Christopher 
Malyszewicz. The full toe-curling account can 
be read in Goldacre’s book Bad Science, but 
the short story is that Dr Malyszewicz’s lab was 
described by the journalists as ‘the lab that always 
gives positive results’. The News of the World 
described him as a ‘respected MRSA specialist’ 
and The Sun called him ‘the UK’s top MRSA 
expert’; however, it became apparent that he 
was qualified only inasmuch as he held a BSc 
from Leicester Polytechnic and a non-accredited 
correspondence course PhD but, crucially, no 
training in microbiology. His microbiology 
laboratory was a shed in his garden that used 
kitchen units as laboratory benchware. Somewhat 
curiously, the tabloids appeared to view him as a 
solitary heroic crusader attempting to turn the tide 
of an indifferent system, much like Dr Wakefield 
of MMR/autism infamy. Astonishingly, when 
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challenged about their articles by accredited, 
renowned and world-class microbiology 
laboratories such as University College Hospital’s, 
the tabloids maintained their positions, implying 
that their position was concrete based on 
Malyszewicz’s ‘research’ even in the face of 
overwhelming evidence to the contrary from 
respected institutions.
7. Thalidomide
Thalidomide became infamous in the late 1950s 
and 1960s for being identified as the cause of 
birth defects in children born to mothers who 
had taken it as an anti-emetic (anti-nauseant) 
during pregnancy (https://en.wikipedia.org/wiki/
Thalidomide). It was originally made and sold 
in 1953 by Chemie Grünenthal as a sedative or 
hypnotic after its toxicity had successfully been 
tested on several animal models. Once it came into 
general use, it was noticed by Chemie Grünenthal 
researchers that it had anti-emetic properties. This, 
plus the fact that in Germany it was being sold 
as an over-the-counter (OTC) drug as opposed 
to prescription-only medicine (POM), led to its 
use by pregnant women as an anti-emetic. The 
company marketed the drug thus, claiming that 
the reduction in morning sickness in expectant 
mothers made it a ‘wonder drug’. Times have 
clearly changed and nowadays no drug could be 
breezily given to pregnant women without rigorous 
and painstaking testing. However, in the 1950s 
compliance protocols were very different and 
pharmacovigilance less diligent. Instances of babies 
being born with phocomelia (malformation of 
limbs) started appearing and were eventually traced 
back to the use of thalidomide. In this regard, 
thalidomide is said to be teratogenic (from Greek 
for ‘monster forming’); this is also an example of 
how times have changed in terminology. Many 
scientific terms, when considered in isolation, 
would now be considered to be hurtful or offensive: 
cyclopia, cyclopamine, and red, white and brown 
dwarves (classes of imploded stars). Thalidomide 
was marketed in 46 countries, including most of 
Europe and the UK, and by the early 1960s 10 000 
children had been affected with phocomelia.
The precise mechanism by which thalidomide 
causes its teratogenicity is not fully understood 
but it has two enantiomers (non-superimposable 
mirror images, not unlike left and right gloves). 
One of these acted as a sedative and anti-emetic, 
and the other as a teratogen (Figure 2). Separating 
the enantiomers in the hope of using only the 
non-harmful one would not achieve the desired 
result: thalidomide racemises (changes from an 
optically pure compound that consists of only one 
enantiomer into a mixture of two enantiomers). 
This can happen in vivo due to the acidic 
hydrogen on the chiral centre.
The one country where thalidomide was 
not licensed for use was the USA, and this was 
due to the diligence of an FDA (Food and Drug 
Administration) worker called Frances Oldham 
Kelsey. Kelsey ran some animal model tests 
on rats and found that thalidomide acted as an 
abortifacient in rats. In humans, in the doses used, 
it was teratogenic and not an abortifacient. Kelsey 
prevented probably thousands of birth defects by 
meticulous lab work. 
8. Beta blockers and hypertension
In some cases, ‘cause and effect’ for diseases 
and treatments have been misunderstood, despite 
appropriate understanding of the statistics. Let us 
consider the example of drug treatment for high 
blood pressure (hypertension). The heart acts as 
a pump to move blood around the body; in doing 
this, it generates pressure within the fluid of the 
blood. Blood pressure is measured in millimetres 
of mercury (mm Hg), i.e. the height to which the 
pressure in the blood vessel can push a column 
of mercury: 1 mm Hg is equivalent to 133.3 Pa. 
Unlike a domestic central heating system, however, 
Figure 2 The R- and S- enantiomers of thalidomide
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the veins and arteries through which the blood 
flows are not rigid, they are able to contract and 
stretch. In an average healthy adult, as the heart 
contracts (systole), it generates a blood pressure of 
120 mm Hg and, as the heart relaxes (diastole), the 
pressure falls to 80 mm Hg. High blood pressure, 
above about 140 mm Hg systolic and 90 mm Hg 
diastolic, is known to be a major risk factor for 
stroke, heart failure, dementia and premature 
death. For each 2 mm Hg above normal, there is a 
10% increase in the risk of mortality from stroke. 
It has been recognised for a long time, therefore, 
that lowering blood pressure is a logical approach 
to decreasing the risk of stroke, heart failure, 
dementia and premature death. At times of stress, 
the adrenal gland secretes adrenaline that acts to 
increase the rate and force of contractions of the 
heart and to dilate the lungs to allow better gas 
exchange. As part of this ‘fight or flight’ response, 
adrenaline causes constriction of the blood vessels 
supplying the gut and skin, and dilation of the 
blood vessels supplying muscle and the brain. 
This is achieved by adrenaline acting via two 
different sub-types of receptor, alpha and beta 
receptors. Alpha receptors are responsible for the 
vasoconstriction that decreases blood flow to the 
gut and skin while beta receptors are responsible 
for the vasodilation of the blood vessels supplying 
muscle. Beta receptors cause the heart to increase 
the rate and force of its contractions and cause 
bronchodilation in the lungs. In 1965, Goodman 
and Gilman’s textbook The Pharmacological Basis 
of Therapeutics (commonly referred to as the Blue 
Bible; originally Goodman and Gilman (1965), 
now Brunton, Knollman and Hilal-Danden (2017)) 
discussed a newly emerging class of drugs called 
the beta blockers. These drugs were seen to block 
the effects of adrenaline on the beta receptors and 
therefore prevented the increase in rate and force 
of cardiac contraction. There was a consequent 
decrease in blood pressure.
In a later edition of the same textbook, in 
1975, the beta blocker propranolol was reported 
to be effective at treating moderate hypertension 
when used alongside other drug therapies. By the 
time of the publication of the eighth edition of the 
textbook in 1990, the relevant part of the chapter 
on antihypertensive agents read:
[Beta blockers] were not thought to have 
antihypertensive effects when they were first 
investigated . . . [the] antihypertensive effect was 
subsequently demonstrated for propranolol and 
all other [beta blockers] . . . The [beta blockers] 
provide effective therapy for many cardiovascular 
and other diseases, and they are useful for all 
grades of hypertension.
In the UK, the National Institute for Health 
and Clinical Excellence (NICE) published 
its guidelines for the treatment of essential 
hypertension in 2004 (Clinical Guideline 18, see 
Williams et al., 2004) in which it stated:
Drug therapy should normally begin with a low 
dose thiazide-type diuretic. If necessary second 
line add a beta blocker unless the patient is at risk 
of new-onset diabetes.
In younger patients, aged under 55, with 
moderately raised blood pressure and who may be 
managed on one drug, consider beginning with a 
beta-blocker.
Pharmacology textbooks of the time listed 
beta blockers as first- or second-line treatment 
for hypertension, stating that millions of patients 
worldwide were having their hypertension 
controlled by beta blockers alone. By 2006, 
however, NICE guidelines were updated with 
the phrase:
One class of drugs that caused particular 
debate was the beta-blockers. In head-to-head 
trials, beta-blockers were usually less effective 
than a comparator drug at reducing major 
cardiovascular events, in particular stroke.
In the guidelines of 2011 (www.nice.org.
uk/guidance/cg127/chapter/1-guidance), data 
gathered from seven major clinical trials were 
presented to indicate that, although beta blockers 
were effective at lowering blood pressure, 
they did not necessarily prolong life or prevent 
development of other diseases. In terms of all 
causes of death among patients with hypertension, 
those being treated with beta blockers had a risk 
of dying of 94% compared with untreated patients, 
i.e. those receiving placebo. The probability of 
this marginal decrease in risk having occurred by 
chance was determined as being 16%, i.e. beta 
blockers did not significantly decrease mortality 
in patients with hypertension and two of the 
seven trials suggested that patients receiving beta 
blockers were more likely to die. Furthermore, 
beta blockers only decreased the risk of heart 
attack (myocardial infarction) to 92%; again the 
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probability that this marginal decrease was due 
to chance was assessed as 76%, with two of the 
trials showing greater risk for beta blocker users. 
For stroke, the reduction was to 81%, but this was 
also seen to be non-significant, and the probability 
that the reduction occurred due to chance was 8%, 
though no trial showed beta blockers to be worse 
than placebo.
The lesson learned from this sequence of 
events is that high blood pressure is associated 
with increased risk of heart disease, stroke, 
dementia, heart failure, etc. The perceived logic 
was that drugs that lowered blood pressure 
would therefore decrease the risks of the other 
problems. The search was thus on to find drugs to 
lower blood pressure: beta blockers lower blood 
pressure and therefore became a popular form of 
antihypertensive medication. What was forgotten 
was that the aim of the treatment was actually 
to decrease the risk of heart disease, stroke, 
dementia, heart failure, etc., not to lower blood 
pressure. When the effects of the beta blockers 
on these other conditions were investigated, 
they were found to be small. The most recent 
guidelines for the treatment of hypertension state 
that beta blockers are not the preferred therapy 
for hypertension – they are only recommended 
for particular patients (such as pregnant women) 
and as a final resort when all other treatments 
have failed.
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